实时全球研报
SBI Life Q1FY27: Healthy growth with margin pressure from group business; Positive trajectory ahead
研报英文原文证据摘录
SBI Life Q1FY27: Healthy growth with margin pressure from group business; Positive trajectory ahead
our estimate of the market cap.
We value SBI Life at INR 2,440 per share, or an implied ~2.6x FY27E embedded value. This translates to ~18x FY28 new business
profits.
RISKS
SBI Life Insurance Co Ltd
Downside risks
• Our positive thesis relies on continued strong alignment between SBI Life and its distribution partner and parent entity,
State Bank of India. Any weakening of the alignment in terms of lower counter-share or higher commissions charged by the
distribution channel could pose a downside risk to our thesis. We see this as a low probability event, barring regulations (media
reports indicate some regulations on this front are under discussion).
• Implementation of IFRS reporting can introduce a headwind for profitability/ valuation assessment for SBI Life, and the broader
Indian life insurer pack in FY28.
• Indian life insurers have witnessed a period of regulatory flux over the last few years. While we expect regulatory uncertainty
to reduce, regulatory risks from the government/regulator would present a key risk to SBI Life’s stock performance.
RATINGS DEFINITIONS, BENCHMARKS AND DISTRIBUTION
EQUITY RATINGS DEFINITIONS
Bernstein brand
The Bernstein brand rates stocks based on forecasts of relative performance for the next 12 months versus the S&P 500 for
stocks listed on the U.S. and Canadian exchanges, versus the Bloomberg Europe Developed Markets Large and Mid Cap Price
Return Index EUR (EDME) for stocks listed on the European exchanges and emerging markets exchanges outside of the Asia
Pacific region, versus the Bloomberg Japan Large and Mid Cap Price Return Index USD (JPL) for stocks listed on the Japanese
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器